lipitor and crestor
After randomization, patients were treated for 16 weeks with either Lipitor 10 mg per day or a fixed dose of the comparative agent (Table 7). Adverse Reaction* Any dose N=8755 10 mg N=3908 20 mg N=188 40 mg N=604 80 mg N=4055 Placebo N=7311 * lipitor and crestor Reaction ≥ 2% lipitor and crestor any dose greater than placebo Nasopharyngitis 8.3 12.9 5.3 7.0 lipitor and crestor 8.2 Arthralgia 6.9 8.9 11.7 10.6 4.3 6.5 Diarrhea 6.8 7.3 6.4 14.1 5.2 6.3 Pain in extremity 6.0 8.5 3.7 9.3 3.1 5.9 Urinary lipitor and crestor infection 5.7 6.9 6.4 8.0 4.1 5.6 Dyspepsia 4.7 5.9 3.2 6.0 3.3 4.3 Nausea 4.0 3.7 3.7 7.1 3.8 3.5 Musculoskeletal pain 3.8 5.2 3.2 5.1 2.3 3.6 Muscle Spasms 3.6 4.6 4.8 5.1 2.4 3.0 Myalgia 3.5 3.6 5.9 8.4 2.7 3.1 Insomnia 3.0 2.8 1.1 5.3 2.8 2.9 Pharyngolaryngeal pain 2.3 3.9 1.6 2.8 0.7 2.1 Other adverse reactions reported in placebo-controlled studies include: Body as lipitor and crestor whole: malaise, pyrexia; Digestive system: abdominal discomfort, eructation, flatulence, hepatitis, cholestasis; Musculoskeletal system: musculoskeletal pain, muscle fatigue, neck pain, joint swelling; Metabolic and nutritional system: transaminases increase, liver function test abnormal, blood alkaline phosphatase increase, creatine phosphokinase increase, hyperglycemia; Nervous system: nightmare; Respiratory system: epistaxis; Skin and appendages: urticaria; Special senses: vision blurred, tinnitus; Urogenital system: white blood cells urine positive. Your liver function may also need to be tested. Data given as % change represent % difference relative to atorvastatin alone lipitor and crestor 0% = no change). In patients with Fredrickson Types IIa and IIb hyperlipoproteinemia pooled from 24 controlled trials, the median (25th and 75th percentile) percent changes from baseline in HDL-C for Lipitor 10, 20, 40, and 80 mg were 6.4 (-1.4, 14), lipitor and crestor (0, 17), 7.8 (0, 16), and 5.1 (-2.7, 15), respectively. 12.3 Pharmacokinetics Absorption: Lipitor is rapidly absorbed after oral administration; maximum plasma concentrations occur within 1 to 2 hours. Data given as % change represent % difference relative to atorvastatin alone (i.e., 0% = no change). Twenty-five patients with a reduction in LDL-C had a mean response of 20% (range of 7% to 53%, median of 24%); the remaining 4 patients had lipitor and crestor to 24% increases in LDL-C. 8.6 Hepatic Impairment Lipitor is contraindicated in patients with active liver disease which may include unexplained persistent elevations in hepatic transaminase levels . No overall differences in safety or effectiveness were observed between these subjects and younger lipitor and crestor and other reported clinical experience has not identified differences in responses between the elderly and younger patients, but greater sensitivity of some older adults cannot be ruled out. Follow your diet, medication, and exercise routines very closely. Other gastrointestinal side effects observed with HMG-CoA reductase inhibitors have included pancreatitis, anorexia, and vomiting. Lower starting and maintenance doses of atorvastatin should be considered when taken concomitantly with the aforementioned drugs (see Drug Interactions (7)). Male rats given 100 mg/kg/day for 11 weeks prior to lipitor and crestor had decreased sperm motility, spermatid head concentration, and increased abnormal sperm. Elevations of liver enzymes may be dose-related. Following lipitor and crestor of atorvastatin, the patient experienced significant clinical improvement with only mild residual aponeurotic ptosis after 2 months.
Online pharmacy Tags
44 45 46 47 48 49 50 51 52
.